← FDA Drug Approvals (Drugs@FDA)
EVEROLIMUS
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVUGEN · Approved 2025-10-30
Drug application
- FDA Application #
ANDA219955- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EVEROLIMUS
- Generic name
- EVEROLIMUS
- Active ingredients
- EVEROLIMUS
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NOVUGEN
- Manufacturer
- Novugen Pharma (USA) LLC.
- First approval
- 2025-10-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown